Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Chemomab Therapeutics Ltd. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 2.81M | 2.66M | −152.2K (−5.4%) |
| Value | $1.43M | $2.07M | +$638.5K (+44.5%) |
New holders (3)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 26,185 | $20.4K | 0.00% |
| Susquehanna International Group, LLP | 11,477 | $8.94K | 0.00% |
| JPMorgan Chase & Co | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 32,677 | $16.7K |
| XTX Topco Ltd | 29,047 | $14.8K |
| Virtu Financial LLC | 25,808 | $13.0K |
| Millennium Management LLC | 19,701 | $10.0K |
| Advisor Group Holdings, Inc. | 585 | $297 |